Literature DB >> 46515

Abnormal organic acidurias in mentally retarded patients.

R W Watts, R A Chalmers, A M Lawson.   

Abstract

Urine specimens from 1778 mentally retarded patients and 420 age and sex matched non-retarded controls selected from a general practice have been analysed for non-amino organic acids by a quantitative extraction and gas chromatographic method. The compounds were identified by combined gas chromatography and mass spectrometry. Approximately 5% of the patients had an abnormal organic aciduria. The frequency of abnormalities was slightly higher (about 7%) in a group of 248 severely subnormal children, but not in cases with a family history of mental retardation, retarded sibs, or whose parents were consanguineous. The most frequently observed abnormalities were phenylalanine metabolites in cases of phenylketonuria (about 1%), increased excretion of benzoic acid (about 1%), and increased excretion of 2-oxoglutaric acid with or without raised urinary citric-acid levels (about 1%). The biochemical and clinical significance of these findings is being further investigated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46515     DOI: 10.1016/s0140-6736(75)91281-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Screening for organic acidurias and amino acidopathies in newborns and children.

Authors:  R A Chalmers; P Purkiss; R W Watts; A M Lawson
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

2.  Progress in screening for inborn errors of metabolism.

Authors:  R W Watts
Journal:  Experientia       Date:  1978-02-15

3.  Non-ketotic hyperglycinaemia in a family with an unusual phenotype.

Authors:  T Ando; W L Nyhan; J Bicknell; R Harris; J Stern
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

4.  Seven years of experience with selective screening for organic acidurias.

Authors:  W Lehnert; H Niederhoff
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.